Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Bioorg Med Chem Lett ; 108: 129800, 2024 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-38763480

RESUMO

In a quest to discover new antimalarial and antitubercular drugs, we have designed and synthesized a series of novel triazole-quinazolinone hybrids. The in vitro screening of the triazole-quinazolinone hybrid entities against the plasmodium species P. falciparum offered potent antimalarial molecules 6c, 6d, 6f, 6g, 6j & 6k owing comparable activity to the reference drugs. Furthermore, the target compounds were evaluated in vitro against Mycobacterium tuberculosis (MTB) H37Rv strain. Among the screened compounds, 6c, 6d and 6l were found to be the most active molecules with a MIC values of 19.57-40.68 µM. The cytotoxicity of the most active compounds was studied against RAW 264.7 cell line by MTT assay and no toxicity was observed. The computational study including drug likeness and ADMET profiling, DFT, and molecular docking study was done to explore the features of target molecules. The compounds 6a, 6g, and 6k exhibited highest binding affinity of -10.3 kcal/mol with docked molecular targets from M. tuberculosis. Molecular docking study indicates that all the molecules are binding to the falcipain 2 protease (PDB: 6SSZ) of the P. falciparum. Our findings indicated that these new triazole-quinazolinone hybrids may be considered hit molecules for further optimization studies.


Assuntos
Antimaláricos , Antituberculosos , Desenho de Fármacos , Testes de Sensibilidade Microbiana , Simulação de Acoplamento Molecular , Mycobacterium tuberculosis , Plasmodium falciparum , Quinazolinonas , Triazóis , Antituberculosos/farmacologia , Antituberculosos/síntese química , Antituberculosos/química , Antimaláricos/farmacologia , Antimaláricos/síntese química , Antimaláricos/química , Triazóis/química , Triazóis/farmacologia , Triazóis/síntese química , Mycobacterium tuberculosis/efeitos dos fármacos , Plasmodium falciparum/efeitos dos fármacos , Quinazolinonas/química , Quinazolinonas/farmacologia , Quinazolinonas/síntese química , Camundongos , Relação Estrutura-Atividade , Animais , Estrutura Molecular , Relação Dose-Resposta a Droga , Células RAW 264.7
2.
Chem Biodivers ; 17(2): e1900577, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-31823465

RESUMO

Organopromoter, 2-aminoethanesulfonic acid was used to catalyze the synthesis of a series of structurally intriguing new hybrids thiazolyl acridine-1,8(2H,5H)-diones and dihydropyrido[2,3-d : 6,5-d']dipyrimidine-2,4,6,8(1H,3H,5H,7H)-tetraones for the first time. 2-Aminoethanesulfonic acid is a biobased organopromoter, used to generate four new bonds for the synthesis of new coupled thiazole-based decahydroacridine-1,8-diones. Superior green credentials, operational simplicity, easy work-up and recyclability of the catalyst are the key strengths of this method. The broad substrate scope, mild reaction conditions, short reaction time, cost effectiveness, high atom economy and good to excellent yields make the present method a distinct improvement over existing methods. Spectral (IR, 1 H-NMR,13 C-NMR, Mass) data and elemental analyses confirmed the structures of the titled products. A series of thiazolyl acridine-1,8(2H,5H)-diones and dihydropyrido[2,3-d : 6,5-d']dipyrimidine-2,4,6,8(1H,3H,5H,7H)-tetraones were screened for their antimicrobial activity against four bacterial and three fungal strains.


Assuntos
Acridinas/química , Anti-Infecciosos/síntese química , Piridinas/química , Ácidos Sulfônicos/química , Tiazóis/química , Anti-Infecciosos/química , Anti-Infecciosos/farmacologia , Aspergillus/efeitos dos fármacos , Candida/efeitos dos fármacos , Catálise , Bactérias Gram-Negativas/efeitos dos fármacos , Bactérias Gram-Positivas/efeitos dos fármacos , Água/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA